VNA and PACS Market (2024-2031)
The VNA and PACS Market was valued at $3.72 billion in 2023. This market is expected to reach $6.5 billion by 2031, from an estimated $4 billion in 2024, at a CAGR of 7.2% during the forecast period 2024-2031. VNA and PACS Market Size & Forecast Vendor Neutral Archive (VNA) & Picture Archiving and
- Published
- Mar 2024
- Pages
- 250
- Format
- PDF + Excel
- Report ID
- MR-26
- Base year
- 2023
- 2023 · BASELINE
- $3.72B
- 2031
- $6.50B
- CAGR 2024–2031
- 7.2%
2023 baseline · 2024–2031 forecast at 7.2% CAGR · hover a bar for the value
Key highlights
The Departmental PACS Segment is Expected to Account for the Larger Share of the Market in 2024
The On-Premise PACS Segment is Expected to Account for the Largest Share of the Market in 2024
The Enterprise VNA Segment is Expected to Account for the Larger Share of the Market in 2024
The On-Premise VNA Segment is Expected to Account for the Largest Share of the Market in 2024
The Computed Tomography (CT) Segment is Expected to Account for the Largest Share of the Market in 2024
The Independent Software Vendors Segment is Expected to Account for the Largest Share of the Market in 2024
The Hospitals Segment is Expected to Account for the Largest Share of the Market in 2024
Asia-Pacific: Fastest-growing Regional Market
Report summary
| Particulars | Details |
|---|---|
| Number of Pages | ~250 |
| Format | |
| Forecast Period | 2024-2031 |
| Base Year | 2023 |
| CAGR | 7.2% |
| Estimated Market Size (Value) | $6.50 billion by 2031 |
| Segments Covered | By Procurement Model · Departmental PACS · Radiology PACS · Cardiology PACS · Mammography PACS · Traditional Mammography PACS · Vendor Neutral Mammography PACS · Dental PACS · Other Departmental PACS · Enterprise PACS · (Note: Other departmental PACS include pathology, ophthalmology, and orthopedics PACS.) · By Delivery Mode · On-Premise PACS · Web/Cloud-Based PACS · By Procurement Model · Enterprise VNA · Multi-Departmental VNA · Multi-Site VNA · Departmental VNA · By Delivery Mode · On-Premise VNA · Hybrid VNA · Web/Cloud-Based VNA · By Imaging Modality · Computed Tomography (CT) · Angiography · Mammography · Magnetic Resonance Imaging (MRI) · Ultrasound · Other Imaging Modalities · (Note: Other imaging modalities include X-rays and Positron emission tomography (PET).) · By Vendor Type · Independent Software Vendors · PACS Vendors · Infrastructure Vendors · By End User · Hospitals · Diagnostic Imaging Centers · Ambulatory Surgical Centers · Other End Users · (Note: Other end users include universities/education centers, government & non-government organizations, and academic research institutes.) |
| Countries Covered | North America (U.S., Canada), Europe (Germany, France, Italy, U.K., Spain, Switzerland, Rest of Europe) Asia–Pacific (India, China, Japan, South Korea, Australia, Rest of Asia–Pacific), Latin America (Brazil, Mexico, Rest of Latin America), Middle East & Africa. |
| Key Companies | Novarad Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Agfa-Gevaert NV (Belgium), Mach7 Technologies (Australia), GE HealthCare Technologies Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Sectra AB (Sweden), Bridgehead Software, Ltd. (U.K.), INFINITT Healthcare Co., Ltd. (South Korea), Hyland Software, Inc. (U.S.), ASPYRA, LLC (U.S.), Merative L.P. (U.S.), SoftTeam Solutions Pvt Ltd. (India), Carestream Health, Inc. (U.S.), and Neusoft Corporation (China). |
Report overview
Segments covered: procurement, delivery, vendor type, end user. Regions: North America, Europe, Latin America.
Vendor Neutral Archive (VNA) & Picture Archiving and Communication System (PACS) are medical image management solutions used for aiding diagnosis, comparing images between patients or within the same patient at different time points to assess the progress of the disease, and evaluating prognosis. These solutions are used to replace physical archiving by storing all medical image datasets digitally in an organized manner. Such solutions also allow the integration of medical image data with patient data in other records, such as electronic health records, health information systems, and radiology information systems (RIS).
The growth of this market is driven by factors such as the increasing investments in medical imaging technologies, growing demand for imaging equipment, technological advancements in diagnostic imaging modalities, rising geriatric population, thereby increasing imaging volumes, growing big data presence in healthcare, and growing healthcare IT & EHR adoption. Moreover, the integration of PACS/VNA with EMR, penetration of Artificial intelligence (AI) in medical imaging, rising adoption of hybrid & cloud-based medical imaging solutions, and rapidly growing telehealth market are expected to offer significant market growth opportunities.
However, the longer product lifecycle of VNA and budgetary constraints restrain the market’s growth. Additionally, data migration and lack of interoperability pose challenges to the market’s growth.
Among the procurement models of PACS covered in this report, in 2024, the departmental PACS segment is expected to account for the larger share of the PACS market.
The large market share of this segment can be attributed to the increasing adoption of these PACS to process large volumes of images.
Radiology departments use these PACS due to their ability to solve radiology-related issues by digitalizing the traditional process, improving efficiency, ensuring data privacy & security, and enhancing image access.
Most PACS have image viewing & annotation tools built into them to obtain proper conclusions and plan treatment, contributing to their widespread adoption.
Among the procurement models of VNA covered in this report, in 2024, the enterprise VNA segment is expected to account for the larger share of the VNA market.
The large market share of this segment can be attributed to the increasing need to aggregate data across multiple sites to improve care coordination across sites of care.
Moreover, the emergence of Integrated Delivery Networks (IDNs), Accountable Care Organizations (ACOs), and Health Information Exchanges (HIE) and rapid globalization and consolidation further propels the demand for collaborated care & easy access and sharing of data across healthcare settings.
Additionally, multiple hospitals connecting to central repositories and patient mobility between local hospitals and centers are expected to drive the growth of the multi-site VNA market.
Market dynamics
4 factors across 2 forcesIn September 2023,
GE HealthCare Technologies Inc. (U.S.) received more than USD 44 million in funding from the Bill & Melinda Gates Foundation (U.S.) to develop accessible, artificial intelligence (AI)-assisted ultrasound imaging auto-assessment tools and to make ultrasound more available in low-and-middle-income countries.
In October 2021,
DeepSight Technology, Inc. (U.S.) announced raising USD 25 million in Series A funding. DeepSight Technology aims to enhance non-invasive & invasive medical imaging for multiple diagnostic procedures. The company plans to use the funds to advance its medical imaging technology platform and scale its business.
In July 2021,
Exo Imaging, Inc (U.S.) raised USD 220 million in Series C funding to support the company’s plan to deliver a smartphone-connected ultrasound probe, an advanced technology in the medical imaging field.
Table of contents
15 chapters · 130 sections · 250 pages · click to expandSegmental analysis
| Segment | Largest share (2024) | Fastest growth (2024–2031) |
|---|---|---|
| By Delivery | On-Premise PACS | — |
| By Delivery Models Covered in This Report | On-Premise VNA | — |
| By Imaging Modalities Covered in This Report | Computed Tomography (CT) | — |
| By Vendor Types Covered in This Report | Independent Software Vendors | — |
| By End Users Covered in This Report | Hospitals | — |
By Delivery
- The On-Premise PACS Segment is Expected to Account for the Largest Share of the Market in 2024
- Among the delivery modes for PACS covered in this report, in 2024, the on-premise PACS segment is expected to account for the largest share of the PACS market.
- The large market share of this segment can be attributed to the various advantages offered by on-premise PACS, such as high security, control over images, and comparatively lower latency than web/cloud-based PACS are the factors contributing to the significant market share of this segment.
By Delivery Models Covered in This Report
- The on-premise VNA segment is expected to account for the largest share of the VNA market.
- The benefit of the on-premise VNA delivery model, specifically for organizations that are migrating or upgrading from one system to another, is the ability to reuse existing servers and storage hardware.
- Hardware reuse alleviates costs, particularly for smaller organizations that distribute the cost of server hardware over a relatively small number of users.
- Thus, despite the high upfront cost of installation, on-premise models are still preferred by healthcare organizations, mainly due to patient data security and confidentiality, contributing to the significant market share of this segment.
By Imaging Modalities Covered in This Report
- The Computed Tomography (CT) Segment is Expected to Account for the Largest Share of the Market in 2024
- Among the imaging modalities covered in this report, in 2024, the Computed Tomography (CT) segment is expected to account for the largest share of the VNA & PACS market.
- The large market share of this segment can be attributed to the rising demand for imaging services and technological advancement in CT having drastically boosted image resolution, quality, and diagnostic capabilities.
- These improvements have turned CT scanning into a vital tool in medical imaging, resulting in higher demand for storage and administration solutions such as VNA and PACS.
By Vendor Types Covered in This Report
- The independent software vendors segment is expected to account for the largest share of the VNA & PACS market.
- The large market share of this segment can be attributed to the increasing number of hospitals, community centers, and diagnostic imaging centers are turning towards independent software vendors such as Merge Healthcare (IBM), Dejarnette Research Systems, Hyland Software (Acuo), and TeraMedica (Fujifilm) for their vast experience and better functionality, scalability, integration, and support provided for VNA.
By End Users Covered in This Report
- The hospitals segment is expected to account for the largest share of the VNA & PACS market.
- This segment’s large market share can be attributed to the higher patient visits and admissions, efficient management of patient data, and initiatives undertaken to implement advanced technologies.
Geographic analysis
Asia-Pacific
Fastest growthThe market in Asia-Pacific is projected to register the highest growth rate during the forecast period. The growth of this regional market can be attributed to the rising investment in the healthcare sector for improving healthcare infrastructure and digital health, the adoption of advanced imaging modalities into the healthcare industry, and the presence of major VNA & PACS software developers in countries such as China, India, Singapore, and Japan, and technological advancements related to diagnostic imaging, and, government initiatives aiming to increase the utilization of EMR and telehealth services. Asia-Pacific: Fastest-growing Regional Market
Competitive landscape
The report offers a competitive landscape based on an extensive assessment of the software offerings and geographic presence of leading market players and the key growth strategies adopted by them over the past three to four years. The key players profiled in the VNA & PACS market report are Novarad Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Agfa-Gevaert NV (Belgium), Mach7 Technologies (Australia), GE HealthCare Technologies Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Sectra AB (Sweden), Bridgehead Software, Ltd. (U.K.), INFINITT Healthcare Co., Ltd. (South Korea), Hyland Software, Inc. (U.S.), ASPYRA, LLC (U.S.), Merative L.P. (U.S.), SoftTeam Solutions Pvt Ltd. (India), Carestream Health, Inc. (U.S.), and Neusoft Corporation (China).
- Novarad Corporation (U.S.)
- Koninklijke Philips N.V. · Netherlands
- Siemens Healthineers AG · Germany
- Agfa-Gevaert NV · Belgium
- Mach7 Technologies · Australia
- GE HealthCare Technologies Inc. (U.S.)
- Fujifilm Holdings Corporation · Japan
- Sectra AB · Sweden
- Bridgehead Software, Ltd. (U.K.)
- INFINITT Healthcare Co., Ltd. · South Korea
- Hyland Software, Inc. (U.S.)
- ASPYRA, LLC (U.S.)
- Merative L.P. (U.S.)
- SoftTeam Solutions Pvt Ltd. · India
- Carestream Health, Inc. (U.S.)
- Neusoft Corporation · China
Frequently asked questions
This study offers a detailed assessment of the VNA & PACS market and analyzes the market sizes & forecasts based on procurement model, delivery mode, imaging modality, vendor type, and end user. This report also involves the value analysis of various segments and subsegments of the VNA & PACS market at the regional and country levels.
Cite this report
Meticulous Research. (2024). VNA and PACS Market - Global Opportunity Analysis and Industry Forecast (2024-2031) (Report No. MR-26). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/vna-and-pacs-market-4440